Brief: Bioinvent's Partner Oncurious NV Presents Phase I Data On TB-403

BioInvent International AB

12/04/2021 06:35

April 12 (Reuters) - BioInvent International AB  BINV.ST :
    * BIOINVENT'S PARTNER ONCURIOUS NV PRESENTS PHASE I DATA ON
TB-403
IN PEDIATRIC CANCER
    * CONCLUSION FROM PHASE I STUDY IS THAT RESULTS WARRANT
FURTHER
EVALUATION OF TB-403 IN PEDIATRIC SUBJECTS WITH RELAPSED OR
REFRACTORY MEDULLOBLASTOMA (MB)

Source text for Eikon:  ID:nWkrTzJpH 
Further company coverage:  BINV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))